Title : LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway.

Pub. Date : 2019 Dec 7

PMID : 31832001






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSION: PP2A inhibition by LB100 significantly ameliorates hepatic steatosis by regulating hepatic lipogenesis and fatty acid oxidation via the AMPK/Sirt1 pathway. Fatty Acids protein kinase AMP-activated catalytic subunit alpha 2 Homo sapiens